Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart rate changes after reversal of neuromuscular blockade with atropine + neostigmine versus glycopyrrolate + neostigmine
IRCT2015021019470N16Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atropine, neostigmine and glycopyrronium in cataract (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in heart rate following reversal of muscle relaxation. Started Aug 2010; status: completed.
02
Drugs
atropineneostigmineglycopyrronium
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT2015021019470N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015021019470N16.